Skip to main content
Clinical Trials/CTRI/2023/07/055605
CTRI/2023/07/055605
Not yet recruiting
Phase 3

Randomized controlled clinical trial to study the efficacy of Chaturbeej churna in Pushpaghni Jataharini with special reference to polycystic ovarian syndrome - Nil

Swati Suresh Ambekar0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: E282- Polycystic ovarian syndrome
Sponsor
Swati Suresh Ambekar
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Swati Suresh Ambekar

Eligibility Criteria

Inclusion Criteria

  • Diagnosed Cases of PCOS(by Rotterdam criteria)\-any2/3
  • a.Hyperandrogenism(clinical or biochemical)
  • b.oligomenorrhea(menstrual cycle \>35 days)/Secondary amenorrhea
  • c. USG findings\-PCO feature on USG i.e. peripherally arranged antral follicle count \>12 with thickened stroma in ovaries/Ovarian volume \>10cm3 in unilateral/bilateral ovaries.

Exclusion Criteria

  • a.Patient \<16years and \>45years
  • b.Patient showing symptoms other than PCOS
  • c.Patient having any other disease\-causing oligomenorrhea and anovulation excluding PCOS
  • d.Patients suffering from\- adrenal hyperplasia, severe insulin resistance,androgen secreting tumor, thyroid abnormalities, cardiac disease, Cushing syndrome, hyperprolactinemia
  • e. Pregnant patients
  • f.Patients with any organic lesions of reproductive tract like TB,CA,cogenital anomalies,
  • any other pelvic pathologies like fibroids
  • g.A current or previous use (within 3 months) of OCpills,Glucocorticoids,Antiandrogens,Antidiabetic,Antiobesity drugs or any hormonal therepy.

Outcomes

Primary Outcomes

Not specified

Similar Trials